Clinical trial
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function
NCT07269366 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function
- Lead sponsor
- University Medical Center Groningen
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 31, 2026
- Completion date
- May 31, 2034
- Enrollment
- 358 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cabg, cabg in low ef, coronary artery disease, coronary artery disease (cad), heart failure, multivessel coronary artery disease, pci, revascularization